Moderna | MRNA - Equity Capital And Reserves


Moderna reported $8.65B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Agios Pharmaceuticals USD 1.19B 91.22M Dec/2025
Alnylam Pharmaceuticals USD 789.18M 555.28M Dec/2025
Amgen USD 8.66B 961M Dec/2025
Arrowhead Research USD 568.42M 102.37M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.09B 30.29M Dec/2025
Celltrion KRW 16.7T 182.36B Sep/2025
Cspc Pharmaceutical CNY 33.25B 984.93M Jun/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 546.45M 243.38M Sep/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Esperion Therapeutics USD -451.36M 17.85M Sep/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 8.65B 680M Dec/2025
Organigram Holdings CAD 349.13M 36.37M Sep/2025
Ovoca Bio EUR 8.67M 4.76M Jun/2022
Pharma Mar EUR 197.51M 4.02M Sep/2025
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Qiagen NV USD 3.78B 128.73M Dec/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sarepta Therapeutics USD 1.32B 37.26M Sep/2025
Sartorius EUR 2.67B 9.9M Sep/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Tilray USD 1.51B 1.22B Mar/2025
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
United Therapeutics USD 7.1B 506M Dec/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Zz Pientze Pharmaceu CNY 14.47B 173.2M Sep/2025